PAPER Schapira AH, Patel S

Targeting mitochondria for neuroprotection in Parkinson disease.

JAMA Neurol. 2014 May;71(5):537-8. PubMed: 24664140

PAPER Khilari M, Chakkalakkoombil SV, Wadwekar V, Nair PP

Sporadic Creutzfeldt-Jakob disease (sCJD) with asymmetric findings.

BMJ Case Rep. 2014 Mar 24;2014 PubMed: 24663250

PAPER Olanow CW

Parkinson disease: Gene therapy for Parkinson disease--a hope, or a dream?

Nat Rev Neurol. 2014 Apr;10(4):186-7. Epub 2014 Mar 25 PubMed: 24662536

PAPER Chen L, Deltheil T, Turle-Lorenzo N, Liberge M, Rosier C, Watabe I, Sreng L, Amalric M, Mourre C

SK channel blockade reverses cognitive and motor deficits induced by nigrostriatal dopamine lesions in rats.

Int J Neuropsychopharmacol. 2014 Aug;17(8):1295-306. Epub 2014 Mar 24 PubMed: 24661728

PAPER Lin CH, Wu YR, Chen WL, Wang HC, Lee CM, Lee-Chen GJ, Chen CM

Variant R244H in Na+/Mg2+ exchanger SLC41A1 in Taiwanese Parkinson's disease is associated with loss of Mg2+ efflux function.

Parkinsonism Relat Disord. 2014 Jun;20(6):600-3. Epub 2014 Mar 12 PubMed: 24661466

PAPER Jung UJ, Jeon MT, Choi MS, Kim SR

Silibinin Attenuates MPP(+)-Induced Neurotoxicity in the Substantia Nigra In Vivo.

J Med Food. 2014 Mar 24; PubMed: 24660866

PAPER Kazlauskaite A, Kondapalli C, Gourlay R, Campbell DG, Ritorto MS, Hofmann K, Alessi DR, Knebel A, Trost M, Muqit MM

Parkin is activated by PINK1-dependent phosphorylation of ubiquitin at Ser65.

Biochem J. 2014 May 15;460(1):127-39. PubMed: 24660806

Shelly Niu

Medical College

Paula McClean

University of Ulster

Wade Harper

Harvard Medical School
Boston, United States

Prodromal Initiative to Identify Biomarkers for Parkinson’s

CONFERENCE COVERAGE 2014-03-26 Conference Coverage The hunt continues for harbingers of Parkinson’s disease that may one day allow patients to be treated before symptoms take hold. A Keystone conference called “Parkinson’s Disease: Genetics, Mechanisms, and Therapeutics,” held 2-7 Marc

PAPER Lee YC, Lin CH, Wu RM, Lin MS, Lin JW, Chang CH, Lai MS

Discontinuation of statin therapy associates with Parkinson disease: a population-based study.

Neurology. 2013 Jul 30;81(5):410-6. Epub 2013 Jul 24 PubMed: 23884037

Nany Leksokumoro

Ecare - KMF
Jakarta, Indonesia

PAPER Qiang JK, Wong YC, Siderowf A, Hurtig HI, Xie SX, Lee VM, Trojanowski JQ, Yearout D, B Leverenz J, Montine TJ, Stern M, Mendick S, Jennings D, Zabetian C, Marek K, Chen-Plotkin AS

Plasma apolipoprotein A1 as a biomarker for Parkinson disease.

Ann Neurol. 2013 Jul;74(1):119-27. Epub 2013 Aug 6 PubMed: 23447138

PAPER Clark CM, Pratico D, Shaw LM, Leight S, Xie SX, Gu A, Lee VM, Trojanowski JQ

Commentary on "Optimal design of clinical trials for drugs designed to slow the course of Alzheimer's disease." Biochemical biomarkers of late-life dementia.

Alzheimers Dement. 2006 Oct;2(4):287-93. PubMed: 19595902